KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Operating Income: 2009-2024

Historic Operating Income for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $3.9 billion.

  • Cme Group's Operating Income fell 5.04% to $972.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 8.04%. This contributed to the annual value of $3.9 billion for FY2024, which is 14.43% up from last year.
  • Per Cme Group's latest filing, its Operating Income stood at $3.9 billion for FY2024, which was up 14.43% from $3.4 billion recorded in FY2023.
  • Cme Group's Operating Income's 5-year high stood at $3.9 billion during FY2024, with a 5-year trough of $2.6 billion in FY2020.
  • In the last 3 years, Cme Group's Operating Income had a median value of $3.4 billion in 2023 and averaged $3.5 billion.
  • Data for Cme Group's Operating Income shows a peak YoY climbed of 14.43% (in 2024) over the last 5 years.
  • Over the past 5 years, Cme Group's Operating Income (Yearly) stood at $2.6 billion in 2020, then increased by 0.30% to $2.6 billion in 2021, then climbed by 14.01% to $3.0 billion in 2022, then increased by 13.92% to $3.4 billion in 2023, then climbed by 14.43% to $3.9 billion in 2024.